nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—atherosclerosis	0.914	1	CbGaD
Saprisartan—AGTR1—artery—atherosclerosis	0.00663	0.257	CbGeAlD
Saprisartan—AGTR1—endothelium—atherosclerosis	0.0056	0.217	CbGeAlD
Saprisartan—AGTR1—blood vessel—atherosclerosis	0.00516	0.2	CbGeAlD
Saprisartan—AGTR1—ACE Inhibitor Pathway—ACE—atherosclerosis	0.00296	0.0495	CbGpPWpGaD
Saprisartan—AGTR1—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.00269	0.0449	CbGpPWpGaD
Saprisartan—AGTR1—connective tissue—atherosclerosis	0.00265	0.103	CbGeAlD
Saprisartan—AGTR1—cardiovascular system—atherosclerosis	0.0023	0.0893	CbGeAlD
Saprisartan—AGTR1—adipose tissue—atherosclerosis	0.00203	0.0787	CbGeAlD
Saprisartan—AGTR1—ACE Inhibitor Pathway—AGT—atherosclerosis	0.00188	0.0314	CbGpPWpGaD
Saprisartan—AGTR1—liver—atherosclerosis	0.00142	0.0552	CbGeAlD
Saprisartan—AGTR1—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.00138	0.023	CbGpPWpGaD
Saprisartan—AGTR1—Peptide GPCRs—CX3CR1—atherosclerosis	0.00134	0.0224	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PLG—atherosclerosis	0.0011	0.0183	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—HRH1—atherosclerosis	0.00103	0.0172	CbGpPWpGaD
Saprisartan—AGTR1—Peptide GPCRs—EDNRA—atherosclerosis	0.000968	0.0162	CbGpPWpGaD
Saprisartan—AGTR1—Peptide GPCRs—CCR2—atherosclerosis	0.000968	0.0162	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL17A—atherosclerosis	0.000963	0.0161	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRH1—atherosclerosis	0.000924	0.0154	CbGpPWpGaD
Saprisartan—AGTR1—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.000912	0.0152	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CD40—atherosclerosis	0.000854	0.0143	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—HRH1—atherosclerosis	0.000798	0.0133	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL4—atherosclerosis	0.000737	0.0123	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—F2—atherosclerosis	0.000733	0.0122	CbGpPWpGaD
Saprisartan—AGTR1—Arf6 trafficking events—INS—atherosclerosis	0.000697	0.0116	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HRH1—atherosclerosis	0.000684	0.0114	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—UTS2—atherosclerosis	0.000666	0.0111	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—UTS2—atherosclerosis	0.000657	0.011	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL10—atherosclerosis	0.000655	0.0109	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CD40LG—atherosclerosis	0.000655	0.0109	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—CASR—atherosclerosis	0.000638	0.0107	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CX3CR1—atherosclerosis	0.00063	0.0105	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—atherosclerosis	0.000621	0.0104	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CX3CL1—atherosclerosis	0.000618	0.0103	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—FASLG—atherosclerosis	0.000609	0.0102	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—UTS2—atherosclerosis	0.000595	0.00994	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—atherosclerosis	0.000582	0.00972	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—atherosclerosis	0.000571	0.00953	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—HRH1—atherosclerosis	0.000521	0.0087	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL3—atherosclerosis	0.000504	0.00841	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—atherosclerosis	0.000495	0.00826	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CX3CR1—atherosclerosis	0.000493	0.00823	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—atherosclerosis	0.000462	0.00771	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—EDNRA—atherosclerosis	0.000461	0.0077	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CNR2—atherosclerosis	0.000459	0.00765	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—EDNRA—atherosclerosis	0.000455	0.0076	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCR2—atherosclerosis	0.000455	0.0076	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—atherosclerosis	0.000454	0.00758	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—GHRL—atherosclerosis	0.00045	0.0075	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—GHRL—atherosclerosis	0.000444	0.00741	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—UTS2—atherosclerosis	0.000441	0.00736	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CR1—atherosclerosis	0.000423	0.00705	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—atherosclerosis	0.000414	0.00692	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—atherosclerosis	0.000413	0.00689	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—atherosclerosis	0.000402	0.00671	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK3—atherosclerosis	0.000397	0.00662	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—KNG1—atherosclerosis	0.000395	0.00659	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CNR2—atherosclerosis	0.000393	0.00656	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—KNG1—atherosclerosis	0.00039	0.0065	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IFNG—atherosclerosis	0.000385	0.00643	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL4—atherosclerosis	0.000377	0.00629	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—atherosclerosis	0.000359	0.006	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL8—atherosclerosis	0.000358	0.00598	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—atherosclerosis	0.000357	0.00595	CbGpPWpGaD
Saprisartan—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRA—atherosclerosis	0.000357	0.00595	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—atherosclerosis	0.000353	0.00589	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL1B—atherosclerosis	0.000343	0.00573	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.000338	0.00564	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—UTS2—atherosclerosis	0.000336	0.0056	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—EDN1—atherosclerosis	0.000333	0.00555	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—EDN1—atherosclerosis	0.000328	0.00548	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL5—atherosclerosis	0.000326	0.00544	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CX3CR1—atherosclerosis	0.000322	0.00537	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CASR—atherosclerosis	0.000322	0.00537	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CX3CL1—atherosclerosis	0.000316	0.00527	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.000313	0.00522	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.000306	0.0051	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.000306	0.0051	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CNR2—atherosclerosis	0.000299	0.00499	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.000298	0.00497	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.000297	0.00497	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—HRH1—atherosclerosis	0.000294	0.00491	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—VEGFA—atherosclerosis	0.000291	0.00486	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—AGT—atherosclerosis	0.000276	0.00461	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—AGT—atherosclerosis	0.000273	0.00455	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—AKT1—atherosclerosis	0.000268	0.00447	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—HRH1—atherosclerosis	0.000267	0.00446	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TGFB1—atherosclerosis	0.000267	0.00446	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.000261	0.00436	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL3—atherosclerosis	0.000257	0.00429	CbGpPWpGaD
Saprisartan—AGTR1—G alpha (q) signalling events—F2—atherosclerosis	0.000255	0.00426	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—F2—atherosclerosis	0.000252	0.0042	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TNF—atherosclerosis	0.000249	0.00416	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.000247	0.00412	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDNRA—atherosclerosis	0.000233	0.00388	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCR2—atherosclerosis	0.000233	0.00388	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.000228	0.00381	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—GHRL—atherosclerosis	0.000227	0.00378	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL2—atherosclerosis	0.000224	0.00375	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00022	0.00368	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.000219	0.00365	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—KNG1—atherosclerosis	0.000199	0.00332	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL4—atherosclerosis	0.000193	0.00323	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—UTS2—atherosclerosis	0.00019	0.00317	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.000183	0.00305	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CASR—atherosclerosis	0.000182	0.00304	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—atherosclerosis	0.000177	0.00296	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—UTS2—atherosclerosis	0.000172	0.00288	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CNR2—atherosclerosis	0.000169	0.00282	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.000169	0.00282	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—EDN1—atherosclerosis	0.000168	0.0028	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL5—atherosclerosis	0.000166	0.00278	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CX3CR1—atherosclerosis	0.000165	0.00276	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CASR—atherosclerosis	0.000165	0.00276	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CX3CL1—atherosclerosis	0.000162	0.0027	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HRH1—atherosclerosis	0.000158	0.00264	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CNR2—atherosclerosis	0.000154	0.00256	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000151	0.00251	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—AGT—atherosclerosis	0.000139	0.00232	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL3—atherosclerosis	0.000132	0.0022	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000131	0.00219	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCR2—atherosclerosis	0.000131	0.00219	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—F2—atherosclerosis	0.000129	0.00215	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—GHRL—atherosclerosis	0.000128	0.00214	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOA4—atherosclerosis	0.000124	0.00207	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000123	0.00206	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCR2—atherosclerosis	0.000119	0.00199	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDNRA—atherosclerosis	0.000119	0.00199	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000119	0.00199	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—GHRL—atherosclerosis	0.000116	0.00194	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL2—atherosclerosis	0.000115	0.00191	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL4—atherosclerosis	0.000114	0.00191	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—KNG1—atherosclerosis	0.000112	0.00188	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOA2—atherosclerosis	0.000107	0.00178	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—KNG1—atherosclerosis	0.000102	0.0017	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—UTS2—atherosclerosis	0.000102	0.0017	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CASR—atherosclerosis	9.76e-05	0.00163	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CX3CR1—atherosclerosis	9.76e-05	0.00163	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CX3CL1—atherosclerosis	9.57e-05	0.0016	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—EDN1—atherosclerosis	9.48e-05	0.00158	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCL5—atherosclerosis	9.4e-05	0.00157	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CNR2—atherosclerosis	9.07e-05	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL8—atherosclerosis	9.06e-05	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MMP3—atherosclerosis	9.05e-05	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	9.03e-05	0.00151	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PRKCG—atherosclerosis	8.94e-05	0.00149	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—EDN1—atherosclerosis	8.61e-05	0.00144	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL5—atherosclerosis	8.54e-05	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PRKCG—atherosclerosis	8.12e-05	0.00136	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VWF—atherosclerosis	8.08e-05	0.00135	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOC3—atherosclerosis	8.03e-05	0.00134	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LDLR—atherosclerosis	7.98e-05	0.00133	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AGT—atherosclerosis	7.87e-05	0.00131	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL3—atherosclerosis	7.8e-05	0.0013	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NCF1—atherosclerosis	7.47e-05	0.00125	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—F2—atherosclerosis	7.27e-05	0.00121	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AGT—atherosclerosis	7.14e-05	0.00119	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDNRA—atherosclerosis	7.05e-05	0.00118	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCR2—atherosclerosis	7.05e-05	0.00118	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CYBA—atherosclerosis	7.02e-05	0.00117	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—PIK3CG—atherosclerosis	6.96e-05	0.00116	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLAT—atherosclerosis	6.87e-05	0.00115	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PARP1—atherosclerosis	6.87e-05	0.00115	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—GHRL—atherosclerosis	6.87e-05	0.00115	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—F2—atherosclerosis	6.6e-05	0.0011	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—PIK3CG—atherosclerosis	6.32e-05	0.00105	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—KNG1—atherosclerosis	6.03e-05	0.00101	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL2—atherosclerosis	5.88e-05	0.000982	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PLG—atherosclerosis	5.84e-05	0.000976	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SOCS3—atherosclerosis	5.53e-05	0.000924	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP3—atherosclerosis	5.34e-05	0.000892	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF2—atherosclerosis	5.32e-05	0.000888	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOB—atherosclerosis	5.17e-05	0.000862	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL8—atherosclerosis	5.12e-05	0.000855	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—EDN1—atherosclerosis	5.08e-05	0.000849	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL5—atherosclerosis	5.04e-05	0.000842	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LPL—atherosclerosis	4.93e-05	0.000824	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PRKCG—atherosclerosis	4.8e-05	0.000801	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SPP1—atherosclerosis	4.67e-05	0.00078	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL8—atherosclerosis	4.65e-05	0.000777	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PDGFB—atherosclerosis	4.32e-05	0.000722	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AGT—atherosclerosis	4.22e-05	0.000704	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEP—atherosclerosis	4.13e-05	0.00069	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOE—atherosclerosis	4.13e-05	0.00069	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CAV1—atherosclerosis	4.1e-05	0.000684	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOA1—atherosclerosis	4.09e-05	0.000682	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—ESR1—atherosclerosis	3.95e-05	0.000659	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—F2—atherosclerosis	3.9e-05	0.000651	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—PIK3CG—atherosclerosis	3.73e-05	0.000623	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—MAPK3—atherosclerosis	3.57e-05	0.000597	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—INS—atherosclerosis	3.53e-05	0.00059	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL2—atherosclerosis	3.48e-05	0.00058	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IGF1—atherosclerosis	3.42e-05	0.00057	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SERPINE1—atherosclerosis	3.24e-05	0.000542	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NOS3—atherosclerosis	3.1e-05	0.000517	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL8—atherosclerosis	2.75e-05	0.000459	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—AKT1—atherosclerosis	2.65e-05	0.000443	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—atherosclerosis	2.61e-05	0.000436	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MMP9—atherosclerosis	2.49e-05	0.000415	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NFKB1—atherosclerosis	2.46e-05	0.000411	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAPK8—atherosclerosis	2.42e-05	0.000404	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—AKT1—atherosclerosis	2.41e-05	0.000402	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFA—atherosclerosis	2.23e-05	0.000373	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT3—atherosclerosis	2.21e-05	0.000369	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—MAPK3—atherosclerosis	2.11e-05	0.000352	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TGFB1—atherosclerosis	2.05e-05	0.000342	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—atherosclerosis	1.54e-05	0.000258	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—AKT1—atherosclerosis	1.42e-05	0.000238	CbGpPWpGaD
